Virtu Financial LLC Buys 47,119 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Virtu Financial LLC grew its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 403.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 58,812 shares of the company’s stock after acquiring an additional 47,119 shares during the quarter. Virtu Financial LLC’s holdings in ASP Isotopes were worth $266,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Barclays PLC raised its stake in ASP Isotopes by 438.5% in the third quarter. Barclays PLC now owns 72,330 shares of the company’s stock valued at $201,000 after purchasing an additional 58,897 shares in the last quarter. Geode Capital Management LLC increased its holdings in ASP Isotopes by 42.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after buying an additional 334,836 shares during the period. Walleye Capital LLC acquired a new position in shares of ASP Isotopes in the 3rd quarter valued at approximately $536,000. Jane Street Group LLC lifted its holdings in shares of ASP Isotopes by 31.7% during the 3rd quarter. Jane Street Group LLC now owns 145,969 shares of the company’s stock worth $406,000 after acquiring an additional 35,166 shares during the period. Finally, State Street Corp boosted its position in shares of ASP Isotopes by 12.8% during the 3rd quarter. State Street Corp now owns 853,695 shares of the company’s stock worth $2,373,000 after acquiring an additional 96,604 shares in the last quarter. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Stock Performance

Shares of NASDAQ:ASPI opened at $4.18 on Friday. The company’s 50 day simple moving average is $5.01 and its 200 day simple moving average is $4.90. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $9.33. The stock has a market capitalization of $298.41 million, a price-to-earnings ratio of -6.85 and a beta of 3.66.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.